The Wall Street Journal

Also in WSJ.com:

International Editions

Market Data

Roka Bioscience Inc. ROKA (U.S.: Nasdaq)

View All companies

AT CLOSE 3:59 PM ET 09/03/14
^$11.29 USD
-0.16 -1.40%
Volume 25,210

AFTER HOURS 4:04 PM ET 08/29/14
^$11.72 0.00 3.81%
AFTER HOURS Vol 125

Volume 25,210
65 Day Avg Vol 111,925
1 Day Range 10.844 - 11.72
52 Week Range 9.15 - 13.00 (07/31/14 - 07/18/14)

Compare

Compare to Benchmark:
DJIA
S&P 500
GLOBAL DOW
NASDAQ
Health Care

Today's Open 11.72
Prior Day Close 11.45 (09/02/14)

Performance Today
ROKA -1.40%
DJIA 0.06%
Russell 2K -0.62%
Health Care 0.29%

Latest News Roka Bioscience Inc.(ROKA)

- 08/11/14
- Dow Jones Newswires
GNC Raised to Outperform From Neutral
- Dow Jones Newswires
- 08/11/14
- Dow Jones Newswires
King Cut to Sector Perform From Outperform by
- Dow Jones Newswires
- 08/11/14
- Press Release
Roka Bioscience Reports Second Quarter 2014 Financial Results
- Press Release
- 08/04/14
- Press Release
Roka Bioscience to Report Second Quarter 2014 Financial Results On August 11, 2014
- Press Release

Key Stock Data

P/E Ratio (TTM): The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
Earnings Per Share (TTM): A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding.
Market Capitalization: Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.
Shares Outstanding: Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
Public Float: The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.
Dividend Yield: A company's dividend expressed as a percentage of its current stock price.

Key Stock Data

P/E Ratio (TTM)
N/A
EPS (TTM)
N/A
Market Cap
^$202.14 M
Shares Outstanding
17.63 M
Public Float
7.22 M
Yield
ROKA has not issued dividends in more than 1 year.
Latest Dividend
N/A
Ex-Dividend Date
N/A

Shares Sold Short: The total number of shares of a security that have been sold short and not yet repurchased.
Change from Last: Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
Percent of Float: Total short positions relative to the number of shares available to trade.

Short Interest

Shares Sold Short
1,358 (08/15/2014)
Change from Last
-72.95%
Percent of Float
0.02%

Money Flow Uptick/Downtick Ratio: Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an "uptick" in price and the value of trades made on a "downtick" in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. Our calculations are based on comprehensive, delayed quotes.

Stock Money Flow

Uptick/Downtick Trade Ratio
N/A

Net Money Flow ($)

Money flow gives a snapshot of relative buying and selling pressure in a stock. A ratio above one suggests greater buying pressure, below one suggests greater selling.

Competitors (ROKA)

Company	Change	P/E (TTM)
STXS Stereotaxis Inc.	-4.04% -0.12	-
HBIO Harvard Bioscience Inc.	-0.22% -0.01	-
PACB Pacific Biosciences of California Inc.	-10.73% -0.62	-
BIOT Biotage AB	+0.90% +0.10	15.34
ELN El.En S.p.A.	+1.67% +0.38	9.60
AJA Analytik Jena AG	-1.13% -0.16	-
7705 GL Sciences Inc.	-2.46% -32.00	8.12
039860 NanoenTek Inc.	-2.84% -190.00	-
VRML Vermillion Inc.	+8.60% +0.19	-

Competitor Data Provided By: capital cube

Profile (ROKA)

Roka Bioscience, Inc. develops molecular assays and instrument systems for the food safety industry. Its products include atlas system, atlas listeria detection assay and atlas salmonella detection assay. Atlas Detection Assays incorporates advanced molecular technologies...

20 Independence Boulevard
Warren New Jersey 07059
United States

Website
Map

Employees -

Sector Medical Equipment
Sales or Revenue 2.18 M

Industry Health Care
1Y Sales Change 1978.10%

Fiscal Year Ends December 31 Download Reports

Research & Ratings Roka Bioscience Inc.(ROKA)

Per-Share Earnings, Actuals and Estimates

ROKA will report Q3 earnings on false

Actual Analyst Range Consensus

5 0 -5 -10

N/A	N/A	N/A	N/A		-0.48	-0.43
Q32013	Q4	Q12014	Q2		Q3	Q4

Q3 2014 Estimate Trends
Current:	^$-0.48
1 month ago:	^$-
3 months ago:	^$-

Q4 2014 Estimate Trends
Current:	^$-0.43
1 month ago:	^$-
3 months ago:	^$-

FY 2014 Estimate Trends
Current:	^$-9.41
1 month ago:	^$-
3 months ago:	^$-

FY 2015 Estimate Trends
Current:	^$-1.47
1 month ago:	^$-
3 months ago:	^$-

Financials Roka Bioscience Inc.(ROKA)

Net Income

0 -3M -6M -9M

Mar 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014

Jun 2014

5-quarter trend

Net Income Growth

Sales or Revenue

1.39 M

Sales or Revenue Growth

EBITDA

N/A	-9.41	-1.47	-1.02
FY 2013	FY 2014	FY 2015	FY 2016

Roka Bioscience Inc. ROKA (U.S.: Nasdaq)

AT CLOSE 3:59 PM ET 09/03/14

Volume 25,210

AFTER HOURS 4:04 PM ET 08/29/14

AFTER HOURS Vol 125

Key Stock Data

P/E Ratio (TTM)

EPS (TTM)

Market Cap

Shares Outstanding

Public Float

Yield

Latest Dividend

Ex-Dividend Date

Short Interest

Shares Sold Short

Change from Last

Percent of Float

Stock Money Flow

Uptick/Downtick Trade Ratio

Net Money Flow ($)

Competitors (ROKA)

Per-Share Earnings, Actuals and Estimates

Net Income

Customer Service

Policy

Ads

Tools & Features

More